Comparison of histamine-releasing factor recovered from skin and peripheral blood mononuclear cells of patients with chronic idiopathic urticaria

Annals of Allergy, Asthma and Immunology

Volumn 77, Issue 6, 1996, Pages 475-479

  Claveau, Joël ^a   Lavoie, Aubert ^a   Brunet, Chantal ^a   Bédard, Pierre Michel ^a   Hébert, Jacques ^a,b  

^a UNIVERSITÉ LAVAL   (Canada)

^b Ctr Rech Immunol R   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; FEMALE; HISTAMINE RELEASE; HUMAN; IDIOPATHIC DISEASE; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; URTICARIA;

EID: 0030458310     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)63353-4     Document Type: Article

References (24)

1. Thueson DO, Speck LS, Lett-Brown MA, Grant JA. Histamine releasing activity (HRA). I. Production by mitogen- or antigen-stimulated human monuclear cells. J Immunol 1979;123: 626-32.
2. Grant JA, Alam R, Lett-Brown MA. Histamine-releasing factors and inhibitors: historical perspectives and possible implications in human illness. J Allergy Clin Immunol 1991;88: 683-93.
3. Sampson HA, Broadbent KR, Bernhisel-Broadbent J. Spontaneous release of histamine from basophils and histamine-releasing factor in patients with atopic dermatitis and food hypersensitivity. N Engl J Med 1989;321: 228-32.
4. Alam R, Rozniecki J, Salmaj K. A mononuclear cell-derived histamine-releasing factor (HRF) in asthmatic patients: histamine release from basophils in vitro. Ann Allergy 1984;53: 66-9.
5. Alam R, Rozniecki J. A mononuclear cell-derived histamine releasing factor in asthmatic patients. II. Activity in vivo. Allergy 1985;40:124-9.
6. Alam R, Rozniecki J, Kuzminska B. A lymphocyte-derived histamine-releasing factor in asthmatic patients. III. Further studies. Ann Allergy 1985;55: 825-9.
7. Brunet C, Bédard PM, Lavoie A, et al. Allergic rhinitis to ragweed pollen. II. Modulation of histamine-releasing factor production by specific immunotherapy. J Allergy Clin Immunol 1992; 89:87-94.
8. Broide DH, Smith CM, Wasserman SI. Mast cells and pulmonary fibrosis: identification of a histamine-releasing factor in bronchoalveolar lavage fluid. J Immunol 1990;145:1838-44.
9. Claveau J, Lavoie A, Brunet C, et al. Chronic idiopathic urticaria: possible contribution of histamine-releasing factor to pathogenesis. J Allergy Clin Immunol 1993;92:132-7.
10. Jacques P, Lavoie A, Bédard PM, et al. Chronic idiopathic urticaria: profiles of skin mast cell histamine release during active disease and remission. J Allergy Clin Immunol 1992;89: 1139-43.
11. Bédard PM, Brunet C, Pelletier G, Hébert J. Increased compound 48/80 induced local histamine release from non-lesional skin of patients with chronic urticaria. J Allergy Clin Immunol 1986;78:1121-5.
12. Greaves MW, Plummer VM, McLaughlan P, Stanworth DR. Serum and cell bound IgE in chronic urticaria. Clin Allergy 1974;4:265-71.
13. Kern F, Lichtenstein LM. Defective histamine release in chronic urticaria. J Clin Invest 1976;57:1369-77.
14. Rosenstreich DL. Chronic urticaria, activated T-cells, and mast cell releasability. J Allergy Clin Immunol 1986; 78:1099-102.
15. Sibbald RG, Cheema AS, Lozinski A, Tarlo S. Chronic urticaria: evaluation of the role of physical, immunologic, and other contributory factors. Int J Dermatol 1991;30:381-6.
16. Juhlin L. Recurrent urticaria: clinical evaluation of 330 patients. Br J Dermatol 1981;104:369-81.
17. Mekori YA, Giorno RC, Anderson P, Kohler PF. Lymphocyte subpopulations in the skin of patients with chronic urticaria. J Allergy Clin Immunol 1983;72:681-4.
18. Elias J, Boss E, Kaplan AP. Studies of the cellular infiltrate of chronic idiopathic urticaria: prominence of T-lymphocytes, monocytes, and mast cells. J Allergy Clin Immunol 1986;78: 914-8.
19. Kaplan AP, Horakova Z, Katz SI. Assessment of tissue fluid histamine levels in patients with urticaria. J Allergy Clin Immunol 1978;61:350-4.
20. Phanuphak P, Schocket AL, Arroyave CM, Kohler PF. Skin histamine in chronic urticaria. J Allergy Clin Immunol 1980;65:371-5.
21. Leatherman JW, Michael AF, Schuntz BA, Hoidel JR: Lung T cells in hypersensitivity pneumonitis. Ann Intern Med 1984;100:390-2.
22. Hunninghake GW, Crystal RG. Pulmonary sarcoidosis: a disorder mediated by excess helper T-lymphocyte activity at sites of disease activity. N Engl J Med 1981;305:429-34.
23. Lichtenstein LM, Osler AG. Studies on the mechanisms of hypersensitivity phenomena. IX. Histamine release from human leukocytes by ragweed pollen antigen. J Exp Med 1964;120: 507-30.
24. Lichtenstein LM, Levy DA. Is desensitization for ragweed hay fever immunologically specific? Int Arch Allergy Appl Immunol 1972;42:615-26.